The University of Kentucky has appointed an accomplished surgeon and researcher to head the Markey Cancer Center who brings an international reputation for excellence and millions of dollars in research funding.
In addition to serving as director of the Markey Center and professor of surgery in the UK College of Medicine, Dr. B. Mark Evers will be physician-in-chief of the oncology service line and will hold the Markey Cancer Foundation Chair.
Evers, who comes to UK from the University of Texas Medical Branch in Galveston, is an internationally recognized gastro-intestinal and endocrine surgeon as well as a prolific researcher who has amassed hundreds of publication credits over the past two decades.
Evers has been continuously funded by the National Institutes of Health (NIH) for the past 17 years. He is currently principal investigator or director for seven externally funded studies, including a prestigious NIH Merit Award, and is a co-investigator for five others. He will bring with him to Kentucky around $5.5 million in multi-year grant funding, including more than $1 million in current-year support. Total grant funding for the research program Evers will bring to Kentucky is expected to be about $14 million at the outset.
“Mark Evers represents the caliber of leadership that can take Markey to new heights of excellence,” said Dr. Michael Karpf, UK’s executive vice president for health affairs. “As we work toward achieving NCI (National Cancer Institute) designation over the next few years, it will be critical to have a top-tier director at the helm.”